These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 18333378)

  • 1. A clinical approach in regression of glomerulosclerosis.
    Stoian M; Radulian G; ChiĊ£ac D; Simion E; Stoica V
    Rom J Intern Med; 2007; 45(2):215-8. PubMed ID: 18333378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of angiotensin II in glomerular injury.
    Ma L; Fogo AB
    Semin Nephrol; 2001 Nov; 21(6):544-53. PubMed ID: 11709802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of glomerulosclerosis with high-dose angiotensin inhibition is linked to decreased plasminogen activator inhibitor-1.
    Ma LJ; Nakamura S; Aldigier JC; Rossini M; Yang H; Liang X; Nakamura I; Marcantoni C; Fogo AB
    J Am Soc Nephrol; 2005 Apr; 16(4):966-76. PubMed ID: 15728787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Trends on Glomerulosclerosis Regression.
    Stoian M; Stoica V
    J Med Life; 2020; 13(2):116-118. PubMed ID: 32728402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal fibrosis and the renin-angiotensin system.
    Fogo AB
    Adv Nephrol Necker Hosp; 2001; 31():69-87. PubMed ID: 11692472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo.
    Brown NJ; Nakamura S; Ma L; Nakamura I; Donnert E; Freeman M; Vaughan DE; Fogo AB
    Kidney Int; 2000 Sep; 58(3):1219-27. PubMed ID: 10972684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The renin-angiotensin system and diabetic nephropathy.
    Gurley SB; Coffman TM
    Semin Nephrol; 2007 Mar; 27(2):144-52. PubMed ID: 17418683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glomerular scarring: can we delay or even reverse glomerulosclerosis by RAAS inhibition?
    Moeller MJ
    Nephrol Dial Transplant; 2010 Jul; 25(7):2101-3. PubMed ID: 20388634
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of the renin-angiotensin-aldosterone system in the progression of renal disease: a critical review.
    Ibrahim HN; Rosenberg ME; Hostetter TH
    Semin Nephrol; 1997 Sep; 17(5):431-40. PubMed ID: 9316211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review.
    Duprez DA
    J Hypertens; 2006 Jun; 24(6):983-91. PubMed ID: 16685192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-renal angiotensin II/AT1 receptor, oxidative stress, inflammation, and progressive injury in renal mass reduction.
    Vaziri ND; Bai Y; Ni Z; Quiroz Y; Pandian R; Rodriguez-Iturbe B
    J Pharmacol Exp Ther; 2007 Oct; 323(1):85-93. PubMed ID: 17636006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACE inhibitors and angiotensin II receptor antagonists in Crohn's disease management.
    Hume GE; Radford-Smith GL
    Expert Rev Gastroenterol Hepatol; 2008 Oct; 2(5):645-51. PubMed ID: 19072342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
    Furumatsu Y; Nagasawa Y; Tomida K; Mikami S; Kaneko T; Okada N; Tsubakihara Y; Imai E; Shoji T
    Hypertens Res; 2008 Jan; 31(1):59-67. PubMed ID: 18360019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease.
    Brewster UC; Perazella MA
    Am J Med; 2004 Feb; 116(4):263-72. PubMed ID: 14969655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The renin-angiotensin system].
    Hilgers KF
    Urologe A; 2009 Aug; 48(8):925-33; quiz 934-5. PubMed ID: 19669119
    [No Abstract]   [Full Text] [Related]  

  • 16. Kidney angiotensin receptors and their role in renal pathophysiology.
    Sandberg K; Ji H
    Semin Nephrol; 2000 Sep; 20(5):402-16. PubMed ID: 11022892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual blockade of renin-angiotensin system in primary focal segmental glomerulosclerosis.
    Singh A
    Nephrol Dial Transplant; 2006 Mar; 21(3):830-1. PubMed ID: 16278255
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibiting the renin-angiotensin system: why and in which patients.
    Berra K; Miller NH
    J Am Acad Nurse Pract; 2009 Jan; 21(1):66-75. PubMed ID: 19125897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of renin-angiotensin-aldosterone system in kidney and heart disease: how much do we need?
    Lim S
    Acta Med Indones; 2008 Jan; 40(1):34-7. PubMed ID: 19054878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of angiotensin II and plasminogen activator inhibitor-1 in progressive glomerulosclerosis.
    Fogo AB
    Am J Kidney Dis; 2000 Feb; 35(2):179-88. PubMed ID: 10676714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.